 - To describe the antibody persistence in terms of anti-pertussis antibody levels anti-PT, and -FHA and in terms of seroprotection rates and GMTs for Diphtheria, Tetanus, and Poliovirus types 1, 2 and 3, just before administration of the booster dose at Visit 1 in all subjects at 4-6 years of age. 